Literature DB >> 11267502

CD4(-)CD8(-) regulatory T cells implicated in preventing graft-versus-host and promoting graft-versus-leukemia responses.

K J Young1, B DuTemple, Z Zhang, G Levy, L Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267502     DOI： 10.1016/s0041-1345(00)02670-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

Review 1.  Double-negative regulatory T cells: non-conventional regulators.

Authors:  Christopher W Thomson; Boris P-L Lee; Li Zhang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy.

Authors:  S Merims; X Li; B Joe; P Dokouhaki; M Han; R W Childs; Z-Y Wang; V Gupta; M D Minden; L Zhang
Journal:  Leukemia       Date:  2011-05-13       Impact factor: 11.528

3.  Infusion of ex-vivo expanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease.

Authors:  P Achita; D Dervovic; D Ly; J B Lee; T Haug; B Joe; N Hirano; L Zhang
Journal:  Clin Exp Immunol       Date:  2018-07-31       Impact factor: 4.330

Review 4.  Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Authors:  Vasudha Sundaravaradan; Kiran D Mir; Donald L Sodora
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

5.  Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection.

Authors:  Vasudha Sundaravaradan; Ramsey Saleem; Luca Micci; Melanie A Gasper; Alexandra M Ortiz; James Else; Guido Silvestri; Mirko Paiardini; John D Aitchison; Donald L Sodora
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

Review 6.  DNT Cell-based Immunotherapy: Progress and Applications.

Authors:  Yingrui Li; Kang Dong; Xueke Fan; Jun Xie; Miao Wang; Songtao Fu; Qin Li
Journal:  J Cancer       Date:  2020-03-31       Impact factor: 4.207

Review 7.  Application of double-negative T cells in haematological malignancies: recent progress and future directions.

Authors:  Xingchi Chen; Dongyao Wang; Xiaoyu Zhu
Journal:  Biomark Res       Date:  2022-03-14

8.  Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.

Authors:  Erin E Hillhouse; Jean-Sébastien Delisle; Sylvie Lesage
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.